Central retinal vein occlusion in hypertensive patients with chronic hepatitis C treated with interferon α and ribavirin

Malik NN, Sheth HG, Ackerman N, Davies N, Mitchell SM. A prospective study of change in visual function in patients treated with pegylated interferon alpha for hepatitis C in the UK. Br J Ophthalmol 2008;92:256–258.CrossRefPubMedGoogle Scholar

Cedar MA, Zancosky KL, Oliva LA, Molloy PJ, Weissgold DJ, Krawitt EL. Continued treatment of chronic hepatitis C despite development of interferon-associated retinopathy. Am J Gastroenterol 2007;102:2612–2613.CrossRefPubMedGoogle Scholar

Ikebe T, Nakatsuka K, Goto M, Sakai Y, Kageyama S. A case of retinopathy induced by intravenous administration of interferon. Folia Ophthalmol Jpn 1990;41:2291–2296.Google Scholar

Okuse C, Yotsuyanagi H, Nagase Y, et al. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006;12:3756–3759.CrossRefPubMedPubMedCentralGoogle Scholar

Han C, O’Day J. Symptomatic interferon retinopathy successfully treated by hypertension management. Br J Ophthalmol 2007;91:1250–1251.CrossRefPubMedPubMedCentralGoogle Scholar